Stay updated on Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial
Sign up to get notified when there's something new on the Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial page.

Latest updates to the Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange Detected- Added a government-funding operating status notice and confirmation that the NIH Clinical Center is open; directs users to updated operating-status sources. - Bumped revision to v3.2.0. - Removed Dengue disease under Genetic and Rare Diseases Information Center resources (v3.1.0).SummaryDifference2%
- Check22 days agoChange DetectedContent shifts from pharmaceutical safety/solution terminology to general chemical/inorganic categories, and updates the revision to v3.1.0.SummaryDifference0.5%
- Check36 days agoChange DetectedRevision updated to v3.0.2 and 'Back to Top' removed. No substantive content changes detected.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check51 days agoChange DetectedThe web page has added significant information regarding drug safety and specific locations related to dengue disease, while removing several terms related to vaccines and other health conditions.SummaryDifference2%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial page.